NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.660
-0.080 (-2.92%)
At close: Nov 5, 2025, 4:00 PM EST
2.760
+0.100 (3.76%)
After-hours: Nov 5, 2025, 6:52 PM EST
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $63.23 million as of November 5, 2025. Its market cap has increased by 373.49% in one year.
Market Cap
63.23M
Enterprise Value
70.17M
1-Year Change
373.49%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since December 4, 2017, NRx Pharmaceuticals's market cap has decreased from $82.80M to $63.23M, a decrease of -23.64%. That is a compound annual growth rate of -3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 65.13M | 145.46% |
| Dec 31, 2024 | 26.53M | -30.71% |
| Dec 29, 2023 | 38.30M | -48.99% |
| Dec 30, 2022 | 75.08M | -73.29% |
| Dec 31, 2021 | 281.11M | 328.57% |
| Dec 31, 2020 | 65.59M | 1.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.56B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |